1. Home
  2. NVCR vs LILA Comparison

NVCR vs LILA Comparison

Compare NVCR & LILA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NVCR
  • LILA
  • Stock Information
  • Founded
  • NVCR 2000
  • LILA 2017
  • Country
  • NVCR Jersey
  • LILA Bermuda
  • Employees
  • NVCR N/A
  • LILA N/A
  • Industry
  • NVCR Medical/Dental Instruments
  • LILA Cable & Other Pay Television Services
  • Sector
  • NVCR Health Care
  • LILA Telecommunications
  • Exchange
  • NVCR Nasdaq
  • LILA Nasdaq
  • Market Cap
  • NVCR 1.8B
  • LILA 1.8B
  • IPO Year
  • NVCR 2015
  • LILA N/A
  • Fundamental
  • Price
  • NVCR $17.49
  • LILA $9.84
  • Analyst Decision
  • NVCR Buy
  • LILA Buy
  • Analyst Count
  • NVCR 5
  • LILA 2
  • Target Price
  • NVCR $26.60
  • LILA $8.65
  • AVG Volume (30 Days)
  • NVCR 1.3M
  • LILA 241.8K
  • Earning Date
  • NVCR 10-30-2024
  • LILA 11-07-2024
  • Dividend Yield
  • NVCR N/A
  • LILA N/A
  • EPS Growth
  • NVCR N/A
  • LILA N/A
  • EPS
  • NVCR N/A
  • LILA N/A
  • Revenue
  • NVCR $549,964,000.00
  • LILA $4,506,800,000.00
  • Revenue This Year
  • NVCR $16.23
  • LILA $2.30
  • Revenue Next Year
  • NVCR $6.09
  • LILA $3.66
  • P/E Ratio
  • NVCR N/A
  • LILA N/A
  • Revenue Growth
  • NVCR 8.33
  • LILA N/A
  • 52 Week Low
  • NVCR $10.87
  • LILA $5.90
  • 52 Week High
  • NVCR $24.74
  • LILA $10.82
  • Technical
  • Relative Strength Index (RSI)
  • NVCR 43.24
  • LILA 55.13
  • Support Level
  • NVCR $15.61
  • LILA $9.70
  • Resistance Level
  • NVCR $17.31
  • LILA $10.13
  • Average True Range (ATR)
  • NVCR 1.29
  • LILA 0.24
  • MACD
  • NVCR 0.05
  • LILA 0.01
  • Stochastic Oscillator
  • NVCR 11.59
  • LILA 70.12

About NVCR NovoCure Limited

NovoCure Ltd serves in the healthcare sector of the United States. Its business involves the development, manufacture and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis and other products and technologies for the treatment of Glioblastoma, Non-smell cell lung cancer and Pancreatic cancer. Geographically, the company derives majority of its revenue from the United States and rest from Germany, Japan and other markets.

About LILA Liberty Latin America Ltd.

Liberty Latin America Ltd is a telecommunications company. It is a provider of video, broadband internet, fixed-line telephony, and mobile services to residential and business customers. The company's reportable segments include C&W Caribbean, Liberty Networks, C&W Panama, VTR, Liberty Puerto Rico, and Liberty Costa Rica. The company generates the majority of its revenue from C&W Caribbean, and Liberty Puerto Rico segments.

Share on Social Networks: